Two Billion-Dollar Market Reports Just Dropped for AI Scheduling in Healthcare — Here's What They Got Right (and Wrong)

Last week, Research and Markets published not one but two market reports forecasting explosive growth in AI-powered healthcare scheduling. The first pegs the AI in Patient Scheduling Software market at $555 million by 2033. The second, covering the broader AI in Medical Scheduling Software category, projects $1.45 billion by 2033.

Both reports predict ~28% compound annual growth. Both name familiar players. And both landed just two days before athenahealth announced something that makes them look conservative.

What the reports got right

The market is real and growing fast

The numbers aren’t shocking to anyone in the space. Healthcare practices are drowning in phone calls, no-shows, and scheduling inefficiency. The reports correctly identify the core drivers:

• Administrative burnout is unsustainable. Manual scheduling leads to double bookings, extended wait times, and staff turnover. AI solves this at scale.
• Patients expect consumer-grade experiences. Online booking, real-time rescheduling, SMS-based interactions — patients want what every other industry already offers.
• Telehealth and value-based care demand smarter scheduling. Virtual care across time zones and outcome-based models both require intelligent appointment management.

They named the right players (mostly)

The $555M patient scheduling report features Hyro, Assort Health, Notable, Voiceoc, Zocdoc, Relatient, and UnityAI alongside legacy giants Epic and Veradigm. The $1.45B medical scheduling report adds Clearwave, eClinicalWorks, and Qualifacts.

These are legitimate competitors. Hyro’s conversational AI and Assort Health’s voice scheduling are genuine products gaining traction in the athenahealth ecosystem.

The growth rate feels right

A 27-28% CAGR through 2033 is aggressive but defensible. Healthcare AI adoption hit an inflection point in 2025. A University of Minnesota study cited in the report found 65% of U.S. hospitals are already using AI-assisted predictive tools for appointment management. The question isn’t whether this market grows — it’s whether 28% is high enough.

What the reports got wrong

They’re measuring the wrong thing

Here’s the fundamental problem: these reports treat “AI scheduling” as a standalone product category. In reality, scheduling is becoming a feature embedded in broader platforms — voice AI, patient engagement suites, and EHR-native tools. Nobody’s buying “AI scheduling software” in isolation anymore. They’re buying intelligent front-office platforms that handle scheduling alongside intake, triage, prior authorization, and patient communication.

Splitting this into a $555M “patient scheduling” report and a $1.45B “medical scheduling” report with different company lists is a symptom of this confusion. The overlap is massive, and the boundaries are artificial.

Missing key players

Neither report mentions Pretty Good AI, which is actively deployed on the athenahealth marketplace serving specialty practices with voice-first scheduling and clinic intelligence. They also miss several voice AI companies that are eating into this market from the communications side rather than the scheduling side.

The reports lean heavily toward traditional software vendors and miss the wave of voice-native AI companies that are redefining how scheduling actually happens — through natural conversation, not portal clicks.

The forecasts may be too low

$555M and $1.45B sound big until you consider that athenahealth alone serves one in five Americans. When the dominant EHR platform builds AI scheduling directly into its product (more on that below), the addressable market shifts dramatically. Third-party scheduling tools either get acquired, integrated, or displaced.

Underestimating the platform play

The reports treat Epic and athenahealth as peer competitors alongside 10-person startups. That’s like listing Apple alongside third-party keyboard apps. When the platform moves, the ecosystem reshapes around it.

The athena announcement: agentic AI goes live

Two days after these reports published, athenahealth dropped an announcement that makes the entire category look different.

On February 19, athenahealth announced the next generation of its AI-native patient engagement suite within athenaOne — and it’s not incremental. Here’s what’s coming:

Patient conversations (text + voice)

• Two-way texting and secure web chat for common patient questions — currently in alpha, broadly available H1 2026
• Virtual front desk voice assistant for inbound calls with multilingual support — available H2 2026
• Handoff to staff when needed, with full context preserved

Waitlist scheduling

• AI automatically identifies open slots from cancellations and texts patients to fill them — H1 2026

Intelligent patient assistant

• Conversational agent in the patient portal and athenaPatient app for rescheduling and billing questions — H2 2026

Enhanced self-scheduling

• Patients describe needs in plain language; the system matches them to the right appointment type, provider, and time — H2 2026

Why this matters

athenahealth isn’t just adding AI features. They’re building agentic communication tools — AI that acts autonomously on behalf of the practice. The keyword in their announcement is “agentic”: these aren’t chatbots answering FAQs. They’re virtual staff members that schedule, reschedule, triage questions, fill cancellations, and handle multilingual calls.

For the marketplace ecosystem, this is both validation and disruption. Every company named in those market reports now has to answer: what do you do that athenaOne can’t?

The real competitive picture

Here’s how the market actually breaks down post-announcement:

Platform-native (athenahealth, Epic): Building AI scheduling directly into the EHR. Advantage: zero integration friction, massive data access, embedded workflows. Risk: moves slowly, feature depth lags specialists.

Voice-first AI (Pretty Good AI, Hyro, Assort Health): Purpose-built conversational AI that handles calls, scheduling, and front-office tasks. Advantage: deeper voice capabilities, specialty workflows, faster iteration. Risk: platform competition.

Scheduling-specific (Zocdoc, Relatient, Notable): Focused scheduling tools with AI augmentation. Advantage: established user bases. Risk: increasingly commoditized as platforms absorb functionality.

Ambient/documentation (Suki AI): Adjacent category crossing into scheduling through voice interaction. Advantage: clinical workflow integration. Risk: different core competency.

The bottom line

These market reports confirm what practitioners already know: AI scheduling in healthcare is a multi-billion-dollar opportunity growing at nearly 30% annually. They’re useful for investor decks and board presentations.

But the real story isn’t in the forecasts — it’s in what happened 48 hours later. athenahealth going agentic means the competitive dynamics of this entire category just shifted. The companies that win won’t be the ones selling “AI scheduling software.” They’ll be the ones delivering intelligent front-office platforms that make the scheduling problem disappear entirely.

The $2 billion question isn’t whether the market exists. It’s whether your solution works with the platform or gets replaced by it.

Sources: Research and Markets — AI in Patient Scheduling Software Market Forecast to 2033 (Feb 17, 2026); Research and Markets — AI in Medical Scheduling Software Market Forecast to 2033 (Feb 17, 2026); BusinessWire — athenahealth Launches Agentic Patient Communication Tools (Feb 19, 2026)